These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2471266)

  • 21. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA; Kolaitis G; Gabathuler R
    J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA class I molecules consistently present internal influenza epitopes.
    Wahl A; Schafer F; Bardet W; Buchli R; Air GM; Hildebrand WH
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):540-5. PubMed ID: 19122146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.
    Esquivel F; Yewdell J; Bennink J
    J Exp Med; 1992 Jan; 175(1):163-8. PubMed ID: 1309852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly synthesized class II MHC chains are required for VSV G presentation to CTL clones.
    Reiss CS; Gapud CP; Keil W
    Cell Immunol; 1992 Jan; 139(1):229-38. PubMed ID: 1309489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the cytotoxic T cell epitopes of mouse hepatitis virus, using elution of viral peptides from class I MHC molecules as an approach.
    Heemskerk MH; Schoemaker HM; Alphen HE; van der Zee R; Joosten I; Spaan WJ; Boog CJ
    Adv Exp Med Biol; 1993; 342():407-12. PubMed ID: 7516109
    [No Abstract]   [Full Text] [Related]  

  • 28. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.
    Braciale TJ; Braciale VL; Winkler M; Stroynowski I; Hood L; Sambrook J; Gething MJ
    J Exp Med; 1987 Sep; 166(3):678-92. PubMed ID: 2442285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
    Reimann J; Böhm W; Schirmbeck R
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y; Watts TH
    J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation. Naturally processed peptides.
    Elliott T; Townsend A; Cerundolo V
    Nature; 1990 Nov; 348(6298):195-7. PubMed ID: 2172837
    [No Abstract]   [Full Text] [Related]  

  • 33. Presentation of an exogenous antigen by major histocompatibility complex class I molecules.
    Ulmer JB; Donnelly JJ; Liu MA
    Eur J Immunol; 1994 Jul; 24(7):1590-6. PubMed ID: 8026520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment.
    del Val M; Hengel H; Häcker H; Hartlaub U; Ruppert T; Lucin P; Koszinowski UH
    J Exp Med; 1992 Sep; 176(3):729-38. PubMed ID: 1324970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    Chen BP; Madrigal A; Parham P
    J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes.
    Vitiello A; Heath WR; Sherman LA
    J Immunol; 1989 Sep; 143(5):1512-7. PubMed ID: 2474602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.
    Eisenlohr LC; Hackett CJ
    J Exp Med; 1989 Mar; 169(3):921-31. PubMed ID: 2784481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.